Metal homeostasis is a critical physiological process that maintains the delicate balance of transition metals—copper, zinc, and iron—within the brain. These metals are essential cofactors for numerous enzymatic reactions, neurotransmitter synthesis, and cellular respiration. However, dysregulation of metal homeostasis is increasingly recognized as a key pathological mechanism in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD)[@que2015].
The brain presents unique challenges for metal regulation due to the [blood-brain barrier](/entities/blood-brain-barrier), high metabolic demand, and the presence of metal-binding proteins involved in aggregation-prone proteins like [amyloid-beta](/proteins/amyloid-beta) (Abeta) and [alpha-synuclein](/proteins/alpha-synuclein) (a-syn)[@toth2022]. This page provides a comprehensive integration of copper, zinc, and iron homeostasis mechanisms and their roles in neurodegeneration.
The brain requires precise regulation of metal ions:
Metal homeostasis is a critical physiological process that maintains the delicate balance of transition metals—copper, zinc, and iron—within the brain. These metals are essential cofactors for numerous enzymatic reactions, neurotransmitter synthesis, and cellular respiration. However, dysregulation of metal homeostasis is increasingly recognized as a key pathological mechanism in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD)[@que2015].
The brain presents unique challenges for metal regulation due to the [blood-brain barrier](/entities/blood-brain-barrier), high metabolic demand, and the presence of metal-binding proteins involved in aggregation-prone proteins like [amyloid-beta](/proteins/amyloid-beta) (Abeta) and [alpha-synuclein](/proteins/alpha-synuclein) (a-syn)[@toth2022]. This page provides a comprehensive integration of copper, zinc, and iron homeostasis mechanisms and their roles in neurodegeneration.
The brain requires precise regulation of metal ions:
Copper enters neurons through the copper transporter CTR1 (SLC31A1) and is distributed by the copper chaperone ATOX1 to target proteins including [ATP7A](/genes/atp7a) and [ATP7B](/genes/atp7b)[@lutsenko2023].
| Protein | Function | Brain Expression |
|---------|----------|------------------|
| CTR1 (SLC31A1) | Copper uptake transporter | High in choroid plexus, neurons |
| ATOX1 | Copper chaperone | Cytosolic, universal |
| ATP7A | Cu-exporting ATPase | Neurons, vascular endothelium |
| ATP7B | Cu-exporting ATPase | Liver, astrocytes |
| CCS | Copper chaperone for SOD1 | Motor neurons, cortex |
In AD, copper binding to amyloid-beta (Abeta) promotes aggregation and toxicity. Copper-Abeta complexes generate reactive oxygen species (ROS) through Fenton-like reactions [@barnham2024]:
Copper homeostasis is also disrupted in AD, with elevated copper in amyloid plaques and altered ATP7A/ATP7B expression [@squitti2023].
In PD, copper deficiency in the substantia nigra may contribute to dopaminergic neuron loss. Copper is a cofactor for tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis. Additionally, copper can bind to alpha-synuclein and promote its aggregation [@wang2024].
Zinc homeostasis is maintained by two families of zinc transporters [@kambe2025]:
Zinc serves as a synaptic neurotransmitter and neuromodulator. Synaptic zinc is released from presynaptic vesicles during neuronal activity and modulates NMDA receptor function, GABAergic signaling, and synaptic plasticity [@sensi2024].
Zinc plays complex roles in Abeta metabolism:
Zinc dysregulation contributes to alpha-synuclein aggregation and dopaminergic neuron vulnerability. Elevated zinc levels in the substantia nigra of PD patients may promote oxidative stress and mitochondrial dysfunction [@chen2025].
Iron homeostasis is tightly regulated by proteins controlling import, export, storage, and sensing [@lane2024]:
| Protein | Function | Role in Neurodegeneration |
|---------|----------|---------------------------|
| Transferrin (TF) | Iron transport | Elevated in CSF of AD/PD |
| Transferrin Receptor 1 (TFR1) | Iron import | Upregulated in degenerating neurons |
| Ferroportin (FPN) | Iron export | Reduced in PD substantia nigra |
| Ferritin (FTH1/FTL) | Iron storage | Elevated in iron accumulation disorders |
| DMT1 | Divalent metal transport | Increased in substantia nigra in PD |
| Hepcidin (HAMP) | Ferroportin regulator | Dysregulated in AD and PD |
Iron accumulation in the brain is a hallmark of AD:
Iron accumulation in the substantia nigra pars compacta (SNc) is one of the earliest pathological findings in PD:
NBIA disorders feature excessive brain iron accumulation due to mutations in genes including:
All three metals can generate oxidative stress through Fenton chemistry:
Fenton reaction: Fe2+ + H2O2 -> Fe3+ + OH- + OH* (hydroxyl radical)
Copper Fenton-like: Cu+ + H2+ -> Cu2+ + OH- + OH*
This produces hydroxyl radicals (OH*), the most reactive ROS species, causing [@halliwell2023]:
Chelating agents can remove excess metals and reduce oxidative stress [@ritchie2023]:
| Agent | Target Metals | Clinical Status |
|-------|---------------|-----------------|
| Deferoxamine (DFO) | Iron | Phase II for AD/PD |
| Deferiprone | Iron | Phase II for PD |
| Clioquinol | Copper, Zinc | Phase II for AD |
| PBT2 | Copper, Zinc | Phase II for AD |
| CuATSM | Copper | Phase I for ALS |
Copper ionophores like CuATSM (Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone)) deliver copper to cells and may restore mitochondrial function [@mcfarland2024].
Zinc supplementation has shown cognitive benefits in some AD trials, though timing and dosage are critical.
Copper, zinc, and iron homeostasis are interconnected: